HC Wainwright & Co. Maintains Buy on Fractyl Health, Raises Price Target to $24

Benzinga · 2d ago
HC Wainwright & Co. analyst Joseph Pantginis maintains Fractyl Health (NASDAQ:GUTS) with a Buy and raises the price target from $8 to $24.